Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Early digns of efficacy!!!!
View:
Post by palinc2000 on Jul 14, 2022 6:35am

Early digns of efficacy!!!!

Also 6 centers
Best surprise in years!!!!!!
Comment by palinc2000 on Jul 14, 2022 6:43am
Hard not to get excited !! The safety profile allows an extraordinary number of cycles  
Comment by canadapiet on Jul 14, 2022 6:47am
Digns.....????? :-) Indeed, looks like really good news, hope (again) the markets react very positively on that news!!!! GLA palinc2000 - (7/14/2022 6:35:23 AM) Early digns of efficacy!!!! Also 6 centers Best surprise in years!!!!!!
Comment by stockman75 on Jul 14, 2022 6:49am
Intersted to hear the medical experts on our boards input on this pr. I am confused a bit on what constitutes efficacy. I have been hearing 30% reduction in tumor size but isn't stabilizing a advanced\progressive disease a great result? Not to mention with less side effects?  So in other words if a drug stops tumor growth with less side effects than current standard is that not a great ...more  
Comment by realitycheck4u on Jul 14, 2022 6:53am
This post has been removed in accordance with Community Policy
Comment by Wino115 on Jul 14, 2022 8:19am
Don't think that's right.  They report prostate and endometrial.  Endo has high sortilin for advanced cancers, prostate less so.
Comment by SPCEO1 on Jul 14, 2022 7:03am
Anything that helps you live longer with minimal side effects is clearly a good thing. But I defer to the medical experts.
Comment by qwerty22 on Jul 14, 2022 8:15am
Just my view but Ali think you need those partial responses. Those are the clearest signs that the drug has anti-tumour activity. Once you have those then the other signs like PSA reduction and prolonged SD add to that. If they have a much larger data set and show very many SD then that is a good stand alone result as well. I think it's about being certain what you have IS anti-tumour activity ...more  
Comment by Wino115 on Jul 14, 2022 8:24am
What's also an amazing stat, from a commercialization angle, is that these patients had an average of 8 previous therapies.  So the resistance angle and the fact nothing else worked, yet this did is an extremely strong and unique therapeutic characteristic.  Really pretty amazing if you were a patient that tried everything, nothing worked --but you took this as one last shot and saw ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities